Immunitybio (IBRX) has had the highest return since January 1, 2026 by a mid-cap US stock, returning 263.4%.
| ASSET | % RETURN |
|---|---|
Immunitybio (IBRX) | 263.37% |
Erasca (ERAS) | 177.36% |
Alumis (ALMS) | 168.99% |
Red Cat (RCAT) | 110.42% |
Hycroft Mining (HYMC) | 90.38% |
USA Rare Earth (USAR) | 84.93% |
Ultra Clean (UCTT) | 68.86% |
Energy Fuels (UUUU) | 66.58% |
Uranium Energy (UEC) | 66.19% |
Americas Silver (USAS) | 60.91% |
Eos Energy Enterprises (EOSE) | 55.86% |
Navitas Semiconductor (NVTS) | 50.53% |
Vicor (VICR) | 49.63% |
Neogen (NEOG) | 43.22% |
Denison Mines (DNN) | 43.07% |
Silvercorp Metals (SVM) | 42.79% |
Twist Bioscience (TWST) | 42.29% |
10X Genomics (TXG) | 42.18% |
Nuscale Power (SMR) | 41.76% |
New Gold (NGD) | 40.69% |
Perpetua Resources (PPTA) | 40.52% |
FormFactor (FORM) | 40.02% |
Endeavour Silver (EXK) | 39.92% |
Astronics (ATRO) | 39.61% |
Applied Digital (APLD) | 37.26% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
